The Lymphoma Study Association

Academic/HospitalWebsite ↗

Also known as: Lymphoma Study Association | The Lymphoma Study Association | The Lymphoma Study Association - LYSA | The Lymphoma Study Association (LYSA)

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jan 1, 2012

Last known activity

Jun 7, 2024

Timeline

2010s

Jan 1, 2012
The Lymphoma Study Association— Founded

Drugs by trial phase (53 distinct, 61 trials)

Phase 3 (36 own, 0 via acquisition)

Phase 2 (17 own, 0 via acquisition)

Indications

Studied for

Recent trials (50)

NCT06284122OfficialPhase 3Jun 7, 2024
NCT06284122CollaboratorPhase 3Jun 7, 2024
NCT06006117Overall official - principal investigatorPhase 3Sep 5, 2023
NCT04802590Overall official - principal investigatorPhase 2Sep 28, 2021
NCT04984837Study chairPhase 2Aug 30, 2021
NCT04842877Study chairPhase 2Jun 11, 2021
NCT04703686Study chairPhase 2Mar 30, 2021
NCT04318080Overall official - principal investigatorPhase 2May 31, 2020
NCT04318080CollaboratorPhase 2May 31, 2020
NCT03276468Overall official - principal investigatorPhase 2Feb 12, 2018
NCT03366272CollaboratorPhase 2/Phase 3Dec 5, 2017
NCT02686346Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2016
NCT02542514Study chairPhase 2Sep 1, 2015
NCT02298257Study directorPhase 2Jun 1, 2015
NCT02298257Overall official - principal investigatorPhase 2Jun 1, 2015

Details

Founded: Lyon, FR Jan 1, 2012
Last known activity: Jun 7, 2024

Notes

Established in February 2012, LYSA is the result of the merger of GELA (The Lymphoma Adult Study Group) and of the Lymphoma Committee of GOELAMS (The West-East Group for the Study of Leukemia and other Blood Diseases).